Square Pharmaceuticals Limited announced that the Board of Directors has decided to establish a pharmaceuticals manufacturing subsidiary company in Nairobi, Kenya. The Initial estimated total project cost will be $20.00 million. $8.00 million of it will be financed by equity investment by the company for which Bangladesh Bank has given permission and the balance would be invested from loan. It is expected that the project would be completed by June 2019.